Wanling Xie

基本信息

浏览量：246

职业迁徙

个人简介

Skills and Expertise
Clinical Trials

研究兴趣

论文共 275 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Long-term Outcomes and Prognostic Impact of Residual Cancer Burden after Intensified Neoadjuvant Therapy in High-risk Prostate Cancer

Praful Ravi,Lucia Kwak, Andres M. Acosta, Saahil Rastogi,Wanling Xie, Aya Abdelnaser,David J. Einstein,Peter Chang,Andrew A. Wagner,Rana R. McKay, Adam S. Kibel, Mary-Ellen Taplin

European Urology (2025)

引用0浏览0WOS引用

Evaluation of Clinical Risk Stratification to Determine Benefit from Long-Term Versus Short-Term Androgen Deprivation in High-Risk Localized Prostate Cancer

Praful Ravi,Wanling Xie,Silke Gillessen,Bertrand Tombal,Daniel E. Spratt,Paul L. Nguyen,Christopher J. Sweeney

Prostate Cancer and Prostatic Diseasespp.1-3, (2025)

引用0浏览0WOSNATURE引用

Association of DAZL Expression with Risk of Recurrence in Clinical Stage 1 Testicular Germ Cell Tumors

Anis Hamid, Jiaming Huang,Caiwei Zhong,Wanling Xie,Emily Rothmann,Peter Nicholls, Nathan Walk,Iva Brcic,Angelika Terbuch,Eliezer Mendel Van Allen,Christopher Sweeney

Journal of Clinical Oncology（2024）

引用0浏览0引用

1702P Updated Results of Phase II Study of Cabozantinib (cabo) with Nivolumab (nivo) and Ipilimumab (ipi) in Advanced Renal Cell Carcinoma with Divergent Histologies (Rccdh)

B.A. McGregor, M. Paul,W. Xie, W. Xu,M.A. Bilen,D.A. Braun,S. Berg, T. Zhang,R.R. McKay,D.F. McDermott,H. Hammers,T.K. Choueiri

Annals of Oncology (2024): S1020

引用0浏览0引用

CDK4/6 Inhibition with Abemaciclib in in Patients (pts) with Previously Treated Advanced Renal Carcinoma (RCC)

Bradley McGregor,Wanling Xie,Wenxin Xu,Stephanie Berg,Srinivas R. Viswanathan,David McDermott,Sabina Signoretti,William Kaelin,Toni Choueiri

ONCOLOGIST (2024)

引用0浏览0WOS引用

17 CDK4/6 Inhibition with Abemaciclib in in Patients (pts) with Previously Treated Advanced Renal Carcinoma (RCC)

Bradley McGregor,Wanling Xie,Wenxin Xu,Stephanie Berg,Srinivas R Viswanathan,David McDermott,Sabina Signoretti,William Kaelin,Toni Choueiri

The Oncologistno. Supplement_1 (2024)

引用0浏览0引用

Expression of the Receptor Tyrosine Kinase AXL and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma Enrolled in the METEOR Trial

Yasmin Nabil Laimon, Morgan Paul,Fatme Ghandour,Nourhan El Ahmar,Sayed Matar,Thomas Denize,Aseman Bagheri Sheshdeh,Varunika Savla, Razan Assaad Mohanna,Maxine Sun,Renee Maria Saliby,Eddy Saad,Marc Machaalani,David A. Braun,Dana T. Aftab,Wanling Xie,Toni K. Choueiri,Sabina Signoretti

Journal of Clinical Oncologyno. 16_suppl (2024): 4543-4543

引用0浏览0引用

Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer

Praful Ravi,Caiwei Zhong,Wanling Xie,Emma Kelly,Bridget Whelpley, Katelyn Kuczmarski,Himisha Beltran,Kerry L. Kilbridge,Martin T. King,Bradley A. McGregor,Alicia K. Morgans,Mark Pomerantz,Mary-Ellen Taplin,Alok K. Tewari,Srinivas R. Viswanathan,Xiao X. Wei,Mai Anh Huynh,Atish D. Choudhury

European Urology Oncology (2024)

引用0浏览0WOS引用

Evaluating Intermediate Endpoints (IE) for Overall Survival (OS) in Metastatic Renal Cell Carcinoma (mrcc) Treated with Immune Checkpoint Inhibitors (ICI): an IMDC Study

Renee Maria Saliby,Wanling Xie,J. Connor Wells,Eddy Saad,Marc Eid,Chris Labaki,Karl Semaan, Evan Ferrier,Audreylie Lemelin,Cristina Suarez,Jose Manuel Ruiz-Morales,Thomas Powles,Lori Wood,Hedyeh Ebrahimi,Guillermo de Velasco,Kosuke null Takemura,Neeraj Agarwal,David A. Braun,Daniel Yick Chin Heng,Toni K. Choueiri

Journal of Clinical Oncologyno. 4_suppl (2024): 400-400

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Statistician

论文共 275 篇作者统计合作学者相似作者